Costs of deep foot infections in patients with diabetes mellitus

PharmacoEconomics

Volumn 18, Issue 3, 2000, Pages 225-238

  Tennvall, G R ^a,b   Apelqvist, J ^b   Eneroth, M ^b  

^a SWEDISH INSTITUTE FOR HEALTH ECONOMICS   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; CADEXOMER IODINE; CEFACLOR; CEFADROXIL; CEFALEXIN; CEFUROXIME; CIPROFLOXACIN; CLINDAMYCIN; CLOXACILLIN; COTRIMOXAZOLE; FLUCLOXACILLIN; GENTAMICIN; INSULIN; METRONIDAZOLE; PENICILLIN G; PENICILLIN V;

ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DIABETES MELLITUS; DIABETIC FOOT; DRUG COST; FEMALE; HEALTH CARE COST; HOSPITALIZATION; HUMAN; LIMB AMPUTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; POSTOPERATIVE CARE; PRIORITY JOURNAL; WOUND HEALING;

EID: 0033864441     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-200018030-00003     Document Type: Article

References (42)

1. Local signs and symptoms in relation to final amputation level in diabetic patients. A prospective study of 187 patients with foot ulcers
2. Decreasing incidence of major amputation in diabetic patients: A consequence of a multidisciplinary foot care team approach?
3. Pathways to diabetic limb amputation. Basis for prevention
4. Evaluation and treatment of the infected foot in a community teaching hospital
5. The diabetic foot in Dutch hospitals: Epidemiological features and clinical outcome
6. The course of severe foot infection in patients with diabetes
7. The acutely infected diabetic foot is not adequately evaluated in an inpatient setting
8. Outpatient management of uncomplicated lower-extremity infections in diabetic patients
9. Can aggressive treatment of diabetic foot infections reduce the need for above-ankle amputation?
10. Foot infections in diabetic patients. Decision and cost-effectiveness analyses
11. Treatment of osteomyelitis in the diabetic foot. Contribution of conservative surgery
12. Osteomyelitis of the foot in diabetic patients
13. Diabetic foot infections. Pathophysiology and treatment
14. The burden of diabetic foot ulcers
15. Systemic antimicrobial treatment of foot infections in diabetic patients
16. Team approach toward lower extremity amputation prevention in diabetes
17. Improved quality of diabetic foot care, 1984 vs 1990. Reduced length of stay and costs, insufficient reimbursement
18. Cost and duration of care for lower extremity ulcers in patients with diabetes
19. Diabetic foot care. Financial implications and practice guidelines
20. Who is at risk of limb loss and what to do about it?
21. Importance of diabetic foot admissions at Middlemore Hospital
22. The dysvascular foot: A system for diagnosis and treatment
23. Medical risk factors in diabetic patients with foot ulcers and severe peripheral vascular disease and their influence on outcome
24. Second European Consensus Document on Chronic Critical Leg Ischemia
25. Clinical characteristics and outcome in 223 patients with deep foot infections
26. Diabetic foot ulcers in a multidisciplinary setting. An economic analysis of primary healing and healing with amputation
27. Topical treatment of diabetic foot ulcers: An economic analysis of treatment alternatives and strategies
28. Cavity foot ulcers in diabetic patients: A comparative study of cadexomer iodine ointment and standard treatment. An economic analysis alongside a clinical trial
29. Toe amputation in the diabetic patient
30. The effects of peripheral vascular disease with osteomyelitis in the diabetic foot
31. Cost effectiveness of early digit amputation in the patient with diabetes
32. Long term prognosis after healed amputation in patients with diabetes
33. Outcome of diabetic foot infections treated conservatively. A retrospective cohort study with long-term follow-up
34. Cost-effective management of diabetic foot ulcers: A review
35. Outcomes associated with diabetes amputations in the Netherlands and in the state of California, USA
36. Long-term costs for foot ulcers in diabetic patients in a multidisciplinary setting
37. Surgery for limb threatening ischaemia: A reappraisal of the costs and benefits
38. Preventive foot care in people with diabetes